🔎 Trials Near Me

Beranda › Kanker (semua jenis) › North Carolina › Winston-Salem

Uji klinis Kanker (semua jenis) di Winston-Salem, NC

19 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Winston-Salem (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Novant Health Cancer Institute - Kernersville, Kernersville · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Menerima pesertaFase 1/2
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06953960

Comprehensive Care for AYA: Needs Assessment Survey

Menerima pesertaStudi observasional
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07196241

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Wake Forest University Health Sciences, Winston-Salem
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

Menerima pesertaStudi observasional
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 50 ke atas · Wanita · Diperbarui 30 Jul 2026 · NCT07046936

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

Menerima pesertaFase 2
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06866964

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

Menerima pesertaStudi observasional
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06634381

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

Menerima pesertaFase 1/2
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT06892522

Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT07278414

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Menerima pesertaFase 1
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05650632

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Menerima peserta
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology, Winston-Salem
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06697600

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

Menerima peserta
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT07119489

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Menerima peserta
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07175376

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Menerima pesertaFase 2
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

Menerima pesertaFase 2
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Usia 18 ke atas · Pria · Diperbarui 13 Apr 2026 · NCT04337580

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Menerima pesertaFase 2
  • Novant Health Forsyth Medical Center /ID# 249533, Winston-Salem
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT04895436

Beat Childhood Cancer Specimen Banking and Data Registry

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • AH Wake Forest Baptist - Brenner Children's Hospital, Winston-Salem
Semua usia · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT04715178

Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit

Menerima peserta
  • Wake Forest University, Winston-Salem
Usia 15 hingga 39 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT07173205

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Winston-Salem
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker (semua jenis) di kota lain

Studi lain di Winston-Salem

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.